Oxidative Medicine and Cellular Longevity

Oxidative Medicine and Cellular Longevity / 2018 / Article

Corrigendum | Open Access

Volume 2018 |Article ID 4818310 | 1 page | https://doi.org/10.1155/2018/4818310

Corrigendum to “Exercise Training Restores Cardiac MicroRNA-1 and MicroRNA-29c to Nonpathological Levels in Obese Rats”

Received04 Dec 2017
Accepted12 Dec 2017
Published25 Feb 2018

In the article titled “Exercise Training Restores Cardiac MicroRNA-1 and MicroRNA-29c to Nonpathological Levels in Obese Rats” [1], an acknowledgment should be added as follows.

This study was supported by Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP—2009/18370-3 and 2010/50048-1); Programa de Inovação Tecnológica/CEPID (Centros de Pesquisa, Inovação e Difusão) (2013/07607-8); USP/PRP: Núcleo de Apoio à Pesquisa com microRNAs-NAP and Pro-Infra; Conselho Nacional de Desenvolvimento Científico e Tecnológico-CNPq (no. 308267/2013-3); Programa PIBIC; and the Brazilian Federal Agency for Support and Evaluation of Graduate Education (CAPES-PROEX).

References

  1. A. C. Silveira, T. Fernandes, Ú. P. R. Soci et al., “Exercise training restores cardiac MicroRNA-1 and MicroRNA-29c to nonpathological levels in obese rats,” Oxidative Medicine and Cellular Longevity, vol. 2017, Article ID 1549014, 12 pages, 2017. View at: Publisher Site | Google Scholar

Copyright © 2018 André C. Silveira et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

447 Views | 205 Downloads | 1 Citation
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19.